10-Q: Rest EZ, Inc. Reports Minimal Revenue and Net Loss in Q1 2025, Cites Going Concern Doubts

Rest EZ, Inc. reports no revenue and a minimal net loss for the quarter ended June 30, 2024, while acknowledging substantial doubt about its ability to continue as a going concern.

Summary

• Rest EZ, Inc. reported its financial results for the quarter ended June 30, 2024.
• The company had no revenue for the three months ended June 30, 2024 and 2023.
• The net loss for the quarter was $33, a decrease from the $5,784 loss in the same period last year.
• General and administrative expenses decreased significantly from $3,710 to $33.
• The company has an accumulated deficit of $321,612 as of June 30, 2024.
• Rest EZ, Inc. acknowledges substantial doubt about its ability to continue as a going concern due to minimal revenue and the need for additional capital.
• The company's continuation is dependent on securing financing and generating profits.
• The company's sole product is a liquid gel capsule named Rest EZ Sleep Aid Supplement.
• The company is marketing the product to wholesalers, retailers, and online.
• The company had previously sold 77,694 bottles for $664,943 in total sales.
• The company's disclosure controls and procedures were deemed ineffective as of June 30, 2024.
• Material weaknesses were identified in internal control over financial reporting, including a lack of sufficient accounting resources and segregation of duties.

Sentiment

Score: 2

Explanation: The document presents a negative outlook due to the lack of revenue, accumulated deficit, going concern warning, and ineffective internal controls. The company's reliance on external financing and the competitive market further contribute to the low sentiment score.

Positives

• The net loss decreased significantly from $5,784 to $33 compared to the same quarter last year.
• General and administrative expenses decreased significantly from $3,710 to $33 compared to the same quarter last year.

Negatives

• The company reported no revenue for the quarter ended June 30, 2024.
• The company has an accumulated deficit of $321,612 as of June 30, 2024.
• The report indicates substantial doubt about the company's ability to continue as a going concern.
• The company's disclosure controls and procedures were deemed ineffective as of June 30, 2024.
• The company identified material weaknesses in internal control over financial reporting.

Risks

• The company's ability to continue as a going concern is uncertain due to minimal revenue and the need for additional capital.
• The company's success depends on securing financing and generating profits.
• The company's disclosure controls and procedures were deemed ineffective.
• Material weaknesses exist in internal control over financial reporting.
• The company is heavily reliant on its sole executive officer and director, Mr. Sosa.
• The company has no proprietary rights to its product.
• The company faces competition from larger, established companies.

Future Outlook

The company plans to build out its reputation and expand to additional wholesalers, retail chain stores, and expand sales to the public over the next twelve months, but its ability to do so is contingent on securing additional financing.

Management Comments

• Mr. Sosa is providing his own facility free of charge until the company needs additional space to store inventory exceeding 100,000 bottles.
• Mr. Sosa indicates he has enough room to store 100,000 bottles of Rest EZ product, so no additional room is needed at this time, or in the near future.

Industry Context

The company operates in the competitive sleep aid supplement market, facing competition from larger, established companies with greater resources. The report highlights the challenges of maintaining profitable operations in this environment.

Comparison to Industry Standards

• It is difficult to compare Rest EZ's performance to industry standards due to its minimal revenue and unique circumstances.
• Larger, established companies in the sleep aid supplement market, such as Nature's Bounty and Natrol, typically have significantly higher revenue and established distribution networks.
• Rest EZ's reliance on a single product and limited marketing efforts contrasts with the diversified product portfolios and extensive marketing campaigns of its competitors.
• The company's going concern warning is a significant deviation from the financial stability typically expected of established players in the industry.

Related Party Transactions

• As of June 30, 2024 and March 31, 2024, Brandon Sosa, President and sole stockholder of the Company, had loaned the Company the amount of $8,188 and $8,188, respectively, for operating capital.
• During the three months ended June 30, 2024 and 2023, the Company charged to operations the amount of $0 and $2,074, respectively, as imputed interest on these loans.
• The Company uses a corporate office located at: 1398 W. Mason Hollow Drive, Riverton, Utah 84065, which is being provided to the Company free of charge by the Company's CEO.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern warning and ineffective internal controls.
• Employees' job security is uncertain due to the company's financial instability.
• Suppliers and creditors may face potential losses if the company is unable to continue operations.

Next Steps

• The company plans to build out its reputation further, and expand to additional wholesalers, retail chain stores, as well as expand sales to the public.
• The company needs to secure additional financing to continue operations.

Key Dates

Keywords

Rest EZ, Going Concern, Financial Results, Net Loss, Revenue, Sleep Aid Supplement, Internal Control, Disclosure Controls